This clinical trial tests the accuracy of a self-collected Papanicolaou test (Pap smear) versus in-clinic screening by a healthcare professional in a clinical setting. Currently, cervical cancer screening in the United States is typically performed by a healthcare provider in the clinical setting. However, self-sampling has been shown to be a viable screening strategy among underserved populations. Information gained from this study may help researchers determine whether self-collected Pap smears are as accurate as provider-collected Pap smears.
Additional locations may be listed on ClinicalTrials.gov for NCT04093388.
Locations matching your search criteria
United States
Alabama
Birmingham
University of Alabama at Birmingham Cancer CenterStatus: Active
Contact: John B. Waits
Phone: 205-312-8080
PRIMARY OBJECTIVES:
I. To test the accuracy of patient self-administered Papanicolaou test (Pap smear) versus in-clinic screening by a healthcare professional in the clinical setting.
II. To study the experience of taking a self-administered Pap smear with the use of a short questionnaire.
OUTLINE:
Participants watch an educational video on Pap smears and then undergo a self-collected vaginal swab sample over 10 minutes and then a healthcare provider-collected vaginal swab sample over 5 minutes on study.
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationUniversity of Alabama at Birmingham Cancer Center
Principal InvestigatorJohn B. Waits
